Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

Contact

Send a question or comment using the form below. This message may be routed through support staff.

Email Article

ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed

Manhattan Institute

search
Close Nav

Manhattan Institute Publishes Letter on FDA Reform in New York Times

press release

Manhattan Institute Publishes Letter on FDA Reform in New York Times

October 16, 2015
Health PolicyFDA Reform

NEW YORK, NY — The Manhattan Institute ran a full-page ad in the New York Times today calling for a new approach to drug approvals that leverages the remarkable scientific advances happening in laboratories at this very moment.

 Centered on the argument that “Everyone will be a patient someday,” the ad calls for “collaboration on an unprecedented scale” to help the FDA integrate the modern marvel of personalized medicine into the drug approval process. It concludes, “A new golden age of medicine is within our grasp. We believe now is the time to seize it.”

Twenty-nine prominent members of the scientific, health care, and policy communities signed the ad, which appears in full below. Click here for more information.

Contact

Communications Department

Manhattan Institute

212-599-7000

communications@manhattan-institute.org

Saved!
Close